November 17, 2005

BKD Management and Regulation

Session 1

Commerce and regulatory considerations for Bacterial Kidney Disease, Chair Kevin Amos

8:30 – 8:50 AM

U.S. perspective on regulatory considerations for R. salmoninarumfor intra and international commerce - Kevin Amos, NOAA Fisheries (presentation pdf)

8:50 – 9:10 AM

Canadian perspective on regulatory considerations for R. salmoninarum for intra and international commerce - Ken Stepushyn, Fisheries and Oceans, Canada

9:10 – 9:30 AM

OIE and EU perspective on regulatory considerations or R. salmoninarum for intra and international commerce – Jim Winton – Western Fisheries Research Center, USGS and OIE Reference Laboratory for BKD (presentation pdf)

9:30 – 10:15 AM

Panel discussion on de-listing of BKD by OIE and direction where the international and domestic regulators need to move.  Jim Winton (Western Fisheries Research Center, USGS), Ole Bendik Dale (Veterinary Institute, Norway), Ken Stepushyn (DFO, Canada). Facilitator - Kevin Amos

10:15 – 10:30 AM

Break

Session 2

Roundtable Discussion: Where do we go next?

Each speaker will have no more than 8 minutes to present their opinion and then the session will be opened up to dialogue between the audience and panel

10:30 – 11:45 AM

Directions and needs from a regulatory perspective - Kevin Amos, NOAA Fisheries

Directions and needs for management of conservation fisheries, with special consideration for ESA-listed salmon populations - Keith Johnson, Idaho Fish and Game Department

BKD: Observations from a practitioner’s point of view – Hugh Mitchell, Novartis

Directions and needs for industry - Per Heggelund, Aquaseed

Directions and needs from a scientific perspective - Mark Strom, NOAA Fisheries

Summary of presentations

11:45 AM – 12:00 PM

Closing Remarks